✦ LIBER ✦

T.P.5.05 Benefits of initiating prednisone treatment in non-ambulatory patients with Duchenne muscular dystrophy (DMD)

✍ Scribed by S. Pandya; D. Fox; K. Fox; C. Westfield; Y. Su; K. Campbell; D. Guntrum; E. Ciafaloni; R.T. Moxley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T.P.5.02 Pentoxifylline treatment fails

✍ D.M. Escolar; K. Gorni; A.C. Tesi-Rocha; J. Mah; Y. Nevo; A. Korengberg; H. Kols 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

G.P.1.03 Increasing survival and changin

✍ S. Pandya; E. Ciafaloni; D. Guntrum; R. Moxley 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

T.P.3.01 Glucocorticoids influence thera

✍ G.M. Buyse; N. Goemans; M. van den Hauwe; I.J.M. de Groot; U. Schara; B. Ceulema 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 43 KB

T.P.3.07 Design of an international phas

✍ G.M. Buyse; T. Meier; R.S. Finkel 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

M.P.5.06 Steroids and T2 relaxation time

✍ H. Kim; T. Laor; B. Dardzinski; M. Chadehumbe; B.L. Wong 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

T.P.5.04 Randomized, double-blind, contr

✍ D. Escolar; C. McDonald; A. Korengberg; T. Bertorini; T. Lotze; M. Ryan; P. Clem 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB